Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions

Abstract Background Detection of appropriate indicators is valuable for preventing incidental osteoporotic fractures. We statistically evaluated the significance of serum cystatin C‐to‐creatinine ratio (CysC/Cr) as a surrogate marker for incident major osteoporotic fractures (MOF) prediction. Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Ichiro Yoshii, Naoya Sawada, Tatsumi Chijiwa
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Journal of General and Family Medicine
Subjects:
Online Access:https://doi.org/10.1002/jgf2.618
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583542993846272
author Ichiro Yoshii
Naoya Sawada
Tatsumi Chijiwa
author_facet Ichiro Yoshii
Naoya Sawada
Tatsumi Chijiwa
author_sort Ichiro Yoshii
collection DOAJ
description Abstract Background Detection of appropriate indicators is valuable for preventing incidental osteoporotic fractures. We statistically evaluated the significance of serum cystatin C‐to‐creatinine ratio (CysC/Cr) as a surrogate marker for incident major osteoporotic fractures (MOF) prediction. Methods Eligible patients with simultaneous measurement of CysC/Cr and bone mineral density in the lumbar spine and proximal femur were selected, and their fracture histories until 5 years after baseline were observed in the retrospective area cohort data. Patients who were followed up until termination or the first osteoporotic fracture were included, and loss of follow‐up or death was excluded. Candidate risk factors for osteoporotic fractures were tested for risk ratios using a cox regression analysis. Receiver operating characteristic tests were performed on factors with significantly higher risk ratios and evaluated with Kaplan‐Meier survival analysis to determine the hazard ratios of the factors. Results A total of 175 patients of whom 28 had incident MOF, 38 men, and 137 women, were enrolled. The mean age was 70.2 years. A significantly higher risk ratio was shown in the presence of prevalent MOF, hyper fall‐ability, lifestyle‐related diseases, chronic kidney diseases ≥ Grade3a, and higher CysC/Cr. All parameters had cutoff indices and showed significantly higher hazard ratios. Conclusions These results suggested that CysC/Cr may be a predictive marker of incident osteoporotic fractures. It might work as a screening tool for MOF risk.
format Article
id doaj-art-a4dfc84cdf714c55828fbaf7276c9d35
institution Kabale University
issn 2189-7948
language English
publishDate 2023-05-01
publisher Wiley
record_format Article
series Journal of General and Family Medicine
spelling doaj-art-a4dfc84cdf714c55828fbaf7276c9d352025-01-28T12:00:52ZengWileyJournal of General and Family Medicine2189-79482023-05-0124317818410.1002/jgf2.618Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictionsIchiro Yoshii0Naoya Sawada1Tatsumi Chijiwa2Department of Musculoskeletal Medicine Yoshii Hospital Shimanto City JapanDepartment of Rheumatology Dohgo Onsen Hospital Rheumatology Center Matsuyama JapanDepartment of Rheumatology Kochi Memorial Hospital Kochi JapanAbstract Background Detection of appropriate indicators is valuable for preventing incidental osteoporotic fractures. We statistically evaluated the significance of serum cystatin C‐to‐creatinine ratio (CysC/Cr) as a surrogate marker for incident major osteoporotic fractures (MOF) prediction. Methods Eligible patients with simultaneous measurement of CysC/Cr and bone mineral density in the lumbar spine and proximal femur were selected, and their fracture histories until 5 years after baseline were observed in the retrospective area cohort data. Patients who were followed up until termination or the first osteoporotic fracture were included, and loss of follow‐up or death was excluded. Candidate risk factors for osteoporotic fractures were tested for risk ratios using a cox regression analysis. Receiver operating characteristic tests were performed on factors with significantly higher risk ratios and evaluated with Kaplan‐Meier survival analysis to determine the hazard ratios of the factors. Results A total of 175 patients of whom 28 had incident MOF, 38 men, and 137 women, were enrolled. The mean age was 70.2 years. A significantly higher risk ratio was shown in the presence of prevalent MOF, hyper fall‐ability, lifestyle‐related diseases, chronic kidney diseases ≥ Grade3a, and higher CysC/Cr. All parameters had cutoff indices and showed significantly higher hazard ratios. Conclusions These results suggested that CysC/Cr may be a predictive marker of incident osteoporotic fractures. It might work as a screening tool for MOF risk.https://doi.org/10.1002/jgf2.618creatininecystatin Cfractureosteoporosisrisk ratiosurrogate marker
spellingShingle Ichiro Yoshii
Naoya Sawada
Tatsumi Chijiwa
Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
Journal of General and Family Medicine
creatinine
cystatin C
fracture
osteoporosis
risk ratio
surrogate marker
title Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
title_full Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
title_fullStr Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
title_full_unstemmed Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
title_short Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
title_sort clinical significance of serum cystatin c to creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
topic creatinine
cystatin C
fracture
osteoporosis
risk ratio
surrogate marker
url https://doi.org/10.1002/jgf2.618
work_keys_str_mv AT ichiroyoshii clinicalsignificanceofserumcystatinctocreatinineratioasasurrogatemarkerforincidentosteoporoticfracturepredictions
AT naoyasawada clinicalsignificanceofserumcystatinctocreatinineratioasasurrogatemarkerforincidentosteoporoticfracturepredictions
AT tatsumichijiwa clinicalsignificanceofserumcystatinctocreatinineratioasasurrogatemarkerforincidentosteoporoticfracturepredictions